Biotech sells pet cloning for $50,000 and cryonics, MIT Technology Review finds

MIT Technology Review surveyed the growing biotech market for pets, from longevity drugs to cloning and cryonics. Startup Loyal is testing its LOY-002 pill in about 1,300 dogs and plans to seek conditional approval in 2027, while Viagen Pets charges $50,000 to clone a cat or dog.

• Loyal tests LOY-002 in about 1,300 dogs, with a 2027 approval filing planned
• Texas-based Viagen Pets clones a cat or dog for $50,000
• Alcor in Arizona stores hundreds of pets and people, recently freezing its first sugar glider
• Experts doubt revival is possible and question the effect on children